News Release

JPMA, PhRMA and EFPIA: Joint Statement on FY2023 NHI Price Revisions

JPMA Statement on the TRIPS Waiver Agreement at the 12th WTO Ministerial Conference

Statement by Research-based Biopharmaceutical Industry on the Trips Waiver Discussions at WTO Ministerial Conference 12

Joint Statement by JPMA PhRMA and EFPIA

JPMA Statement on the informal WTO TRIPS Waiver discussions